APA (7th ed.) Citation

J, S., & J, T. (2020). Evolution in the management of chronic lymphocytic leukemia in Japan: Should MRD negativity be the goal? International journal of hematology, 111(5), 642. https://doi.org/10.1007/s12185-020-02867-0

Chicago Style (17th ed.) Citation

J, Suzumiya, and Takizawa J. "Evolution in the Management of Chronic Lymphocytic Leukemia in Japan: Should MRD Negativity Be the Goal?" International Journal of Hematology 111, no. 5 (2020): 642. https://doi.org/10.1007/s12185-020-02867-0.

MLA (9th ed.) Citation

J, Suzumiya, and Takizawa J. "Evolution in the Management of Chronic Lymphocytic Leukemia in Japan: Should MRD Negativity Be the Goal?" International Journal of Hematology, vol. 111, no. 5, 2020, p. 642, https://doi.org/10.1007/s12185-020-02867-0.